Tuesday – January 3
Healthcare watch –
Bank of America tipped that earnings pre-announcements could jolt shares of Alnylam Pharmaceuticals (ALNY), Amicus Therapeutics (FOLD), Neurocrine Biosciences (NBIX), and Ultragenyx (RARE). Meanwhile, healthcare companies that could provide updates regarding launch metrics on new products and FY22 revenue in early January include Apellis Pharmaceuticals (APLS), argenx (ARGX), and Ascendis Pharma (ASND).
Execs with Nvidia (NVDA) will share some of the company’s latest innovations ahead of the highly anticipated CES trade show in Las Vegas.
8:30 a.m. Edgewise Therapeutics (EWTX) plans to host a virtual investor call to cover preclinical results for its lead cardiac program candidate, EDG-7500.